Company Filing History:
6 out of 441 
2 out of 79 Years Active: 2013-2025
Title: Innovations by Makiko Nakayama: Pioneering Antibody Research in Tokyo
Introduction: Makiko Nakayama is a prominent inventor located in Tokyo, Japan, known for her significant contributions to the field of biotechnology. With a total of five patents to her name, she has developed innovative solutions aimed at treating various medical conditions, particularly in oncology and bone metabolism.
Latest Patents: Among her notable inventions are her latest patents, which include a bispecific antibody designed as a novel anti-tumor agent. This innovative antibody serves a dual purpose, being effective for both anti-tumor treatment and as an active ingredient in therapeutic applications. Additionally, she has developed an Anti-Siglec-15 antibody, which is crucial for treating and preventing abnormal bone metabolism. The pharmaceutical composition she created contains an antibody that specifically recognizes human Siglec-15, effectively inhibiting osteoclast formation, thus addressing critical bone health issues.
Career Highlights: Nakayama’s impressive career includes substantial experience working with reputable organizations in the biotechnology sector. Notably, she has contributed her expertise to Daiichi Sankyo Company, Limited, a prominent pharmaceutical company, and Mie University, enhancing research and development in her field.
Collaborations: Throughout her career, Makiko Nakayama has collaborated with notable professionals such as Yoshiharu Hiruma and Eisuke Tsuda. These collaborations have fostered a productive exchange of ideas and expertise, contributing to her success as an inventor and innovator.
Conclusion: Makiko Nakayama stands out as a key player in the development of biopharmaceutical innovations in Tokyo. Her groundbreaking patents and collaborations illustrate her dedication to advancing medical science, particularly in the fields of oncology and bone health. As she continues her work, her contributions will undoubtedly pave the way for future research and developments in biotechnology.